Recurrent rhabdomyolysis during dabrafenib and trametinib therapy in BRAF V600E-mutated non-small cell lung cancer: a case report

Current Problems in Cancer: Case Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles